Dr Joji Suzuki is a faculty within the Division of Addiction Treatment and Prevention, Psychiatry Department, Mass General Brigham, Brigham and Women’s Hospital (BWH), the inaugural Program Director for the BWH Addiction Medicine Fellowship Program, an Associate Professor of Psychiatry at Harvard Medical School, and the principal investigator of the Suzuki Lab. He completed his medical training at Boston University School of Medicine, general psychiatry residency at Maine Medical Center, and addiction psychiatry fellowship at Boston Medical Center.
His two decades of clinical work span the entire range of inpatient and outpatient substance use disorder treatments, with a particular emphasis on hospital-based addiction consultations. With the goal of embodying the “No Wrong Door” approach to addiction care, his work has contributed to building the capacity for healthcare systems to take responsibility and ownership in addressing addiction as a treatable chronic medical illness using evidence-based treatments.
As a nationally recognized addiction researcher, he has received NIH funding continuously since 2017 and currently dedicates most of his time to clinical and translational research utilizing a range of methodologies spanning clinical trials, qualitative methods, and human laboratory paradigms. Key research areas at the Suzuki Lab include studies to innovate buprenorphine and naltrexone, GLP-1 receptor agonists, and psychedelic medicines as novel treatments for SUD.